BioSpace News Archive

StageZero Life Sciences announced that it will release its First Quarter 2021operational results before market open on Monday, May 17, 2021.

Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, are pleased to announce the acquisition of E Ink’s digital microfluidics unit into the newly formed US subsidiary of Nuclera

Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, recently expanded its patent portfolio to include the perioperative use of Qu’s SSIs to overcome immune dysfunction in patients undergoing cancer surgery.

Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease using bioenergetic nanocatalysis, today announced the presentation of updated blinded interim efficacy data from its ongoing Phase 2 RESCUE-ALS clinical trial.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotulinumtoxinA to decrease the appearance of glabellar lines, also known as frown lines between the eyes.

Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection

Matica Biotechnology, Inc. (Matica Bio) today announced that the Board of Directors has appointed Yun Jeong Song, MD, as the company’s new Chief Executive Officer (CEO) to continue its expansion as a CDMO supporting the global cell and gene therapy industry

CSA Medical, Inc., today announced that all subjects have been enrolled in the RejuvenAir® System study Characterizing the Mechanism of Action of Metered Cryospray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease with Chronic Bronchitis.

Inogen Announces Participation in the 41 st Annual William Blair Virtual Growth Stock Conference

NTx, biomanufacturing and bioinformatics company, announced that biopharma industry veteran Nancy Rurkowski has joined its Board of Directors.